01 May 2004
Quality and safety of organ transplantation.
Kaija SalmelaAnn Transplant 2004; 9(1): 51-52 :: ID: 142792
Abstract
Transplantation, like all medical procedures, carries potential risks forboth donors, recipients and health care personnel. Living donation and associated morbidity and mortalityare documented in living donor registries which, run nationally, are a step toward long-term qualitycontrol in organ transplantation. Such quality control and management should however be a part of allstages of the transplantation process, beginning with donor identification and ending with long-termfollow up of transplant recipients. A whole range of transplantation-related events would be controlled,including organ procurement, handling, risk of disease/malignancy transmission, recipient operation andfollow up. Several international bodies and institutions have formulated statements addressing theseissues. The essential ideas of these documents are focused on protection of human integrity, avoidanceof bodily harm and coercion, exclusion of commercialism, equitable access to transplantation, fairnessof allocation, transparency of the allocation criteria/procedures, competence requirements of the staffand quality management.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






